Results 231 to 240 of about 4,958,749 (292)

Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention

International Forum of Allergy &Rhinology, Volume 16, Issue 10, Page 1073-1083, October 2026.
ABSTRACT Introduction Temperature‐controlled radiofrequency (TCRF), septoplasty (ST) with turbinate reduction, and functional rhinoplasty (FR) are treatment options for nasal airway obstruction (NAO) and nasal valve dysfunction (NVD), but no direct comparison of these procedures has been performed. Methods This prospective, open‐label, non‐inferiority (
Greg Davis, Zeeshan Aziz, Jose Barrera, William Blythe, Chris Davis, Steven Davis, Thomas Higgins, Charles Lano, Gregory Levitin, Frederick Lopatin, Samuel Oyer, Stacey Silvers, Ariel Waitzman, Randall Ow   +13 more
wiley   +1 more source

Gastroesophageal Reflux Disease and Reflux-like Phenotypes: Using Lyon Consensus 2.0 to Guide Clinical Approach. [PDF]

J Neurogastroenterol Motil
Schroeder MK, Gyawali CP.
europepmc   +1 more source

Comorbidities and health‐care use prior to early‐onset Alzheimer's disease: A population‐based case–control study

Alzheimer's &Dementia, Volume 22, Issue 10, October 2026.
Abstract INTRODUCTION We examined whether comorbidities and health‐care use differ between individuals later diagnosed with early‐onset Alzheimer's disease (EOAD) and matched controls during the 15 years preceding diagnosis. METHODS This population‐based case–control study included 407 EOAD patients diagnosed at two Finnish university hospitals (2010 ...
Laura Leppänen, Adolfina Lehtonen, Mikko Aaltonen, Kalle Aho, Ave Kivisild, Abbe Ullgren, Iina Rinnankoski, Helmi Soppela, Annakaisa Haapasalo, Anne M. Portaankorva, Päivi Hartikainen, Kasper Katisko, Eino Solje, Johanna Krüger   +13 more
wiley   +1 more source

Healthcare burden of treated gastroesophageal reflux disease among U.S. adults, 2018-2023: a pooled cross-sectional analysis of the medical expenditure panel survey. [PDF]

Front Med (Lausanne)
Mutalifu M, Mijiti W.
europepmc   +1 more source

Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants

British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3477-3484, October 2026.
Aims The aim of this study is to evaluate the effects of multiple doses of esomeprazole, a strong proton pump inhibitor and acid‐reducing agent, on the pharmacokinetics and safety of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader.
Lana Tran, Naihan Chen, Jennifer A. Winton, Kyle T. Matschke, Smita P. Goodman, Kimberly C. Lee, Yuanyuan Zhang, Weiwei Tan   +7 more
wiley   +1 more source

Treatment procedures for intractable gastroesophageal reflux disease after peroral endoscopic myotomy for achalasia: a retrospective study in South Korea. [PDF]

Clin Endosc
Lee AY, Kim SH, Cho JY.
europepmc   +1 more source

Intermediate‐Phenotype ABCA3 Deficiency Caused by Compound Heterozygous Variants Presenting as Persistent Respiratory Failure and Systemic Hypertension Since Birth in a Term Infant: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT ABCA3 deficiency should be suspected in term infants with persistent respiratory distress from birth. This case highlights how early whole‐exome sequencing established the diagnosis after extensive investigations, identified an intermediate phenotype caused by compound heterozygous variants, and guided targeted multidisciplinary management.
Ammir Abuzahra, Mohamad Abu Mayalah, Mahmoud Abdelrazzaq Abu Mayaleh, Amani Daabes, Rafad Y. Dweik, Abdelrazzaq Abu Mayaleh   +5 more
wiley   +1 more source

Response to Comment on "Substance Use Disorders Are Associated With Increased Long-Term Risks of Gastroesophageal Reflux Disease Phenotypes: A Global Propensity-Matched Cohort Study". [PDF]

Neurogastroenterol Motil
Sun Y, Fass R.
europepmc   +1 more source

The pharmacokinetics and safety of vonoprazan in adolescents and children with gastroesophageal reflux disease. [PDF]

J Pediatr Gastroenterol Nutr
Mulford DJ, Gremse DA, Chang YM, Leifke E, Wagner T, Facius A, Witt G.   +6 more
europepmc   +1 more source